- Home
- ASA vs RXST Comparison
ASA vs RXST Comparison
Compare ASA & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASA
- RXST
- Stock Information
- Founded
- ASA 1958
- RXST 1997
- Country
- ASA United States
- RXST United States
- Employees
- ASA N/A
- RXST N/A
- Industry
- ASA Precious Metals
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ASA Industrials
- RXST Health Care
- Exchange
- ASA Nasdaq
- RXST Nasdaq
- Market Cap
- ASA 622.9M
- RXST 553.1M
- IPO Year
- ASA N/A
- RXST 2021
- Fundamental
- Price
- ASA $31.11
- RXST $7.80
- Analyst Decision
- ASA
- RXST Hold
- Analyst Count
- ASA 0
- RXST 12
- Target Price
- ASA N/A
- RXST $18.45
- AVG Volume (30 Days)
- ASA 81.9K
- RXST 2.1M
- Earning Date
- ASA 08-12-2025
- RXST 08-07-2025
- Dividend Yield
- ASA 0.19%
- RXST N/A
- EPS Growth
- ASA N/A
- RXST N/A
- EPS
- ASA 14.01
- RXST N/A
- Revenue
- ASA $3,923,667.00
- RXST $148,310,000.00
- Revenue This Year
- ASA N/A
- RXST $17.41
- Revenue Next Year
- ASA N/A
- RXST $12.44
- P/E Ratio
- ASA $2.21
- RXST N/A
- Revenue Growth
- ASA 45.39
- RXST 46.70
- 52 Week Low
- ASA $17.42
- RXST $6.32
- 52 Week High
- ASA $35.00
- RXST $58.23
- Technical
- Relative Strength Index (RSI)
- ASA 40.46
- RXST 29.96
- Support Level
- ASA $30.95
- RXST $7.24
- Resistance Level
- ASA $32.56
- RXST $8.31
- Average True Range (ATR)
- ASA 0.87
- RXST 0.39
- MACD
- ASA -0.25
- RXST 0.23
- Stochastic Oscillator
- ASA 4.52
- RXST 55.57
About ASA ASA Gold and Precious Metals Limited
ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company. Its objective is to provide long-term capital appreciation through investing in companies engaged in the exploration for, development of projects, or mining of precious metals and minerals.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.